Early Prediction of Cardio Vascular Disease (CVD) from Diabetic Retinopathy using improvised deep Belief Network

T K Revathi1, B Sathiyabhama1, S Kaliraj2

  • 1Department of CSE, Sona College of Technology, Salem, Tamilnadu, India.

PubMed

Insights

This study introduces an Improvised Deep Belief Network (I-DBN) for early Cardio Vascular Disease (CVD) prediction, achieving 98.95% accuracy. The model integrates Principal Component Analysis and Particle Swarm Optimization for enhanced feature selection and improved diagnostic outcomes.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Cardiology

Background:

  • Cardiovascular Disease (CVD) is a leading cause of mortality, with prediction challenges exacerbated by inadequate early detection systems.
  • Diabetic Retinopathy (DR) is linked to increased CVD risk, highlighting the importance of early DR diagnosis for CVD prevention.
  • Existing classification models often neglect crucial aspects like feature selection and accuracy enhancement.

Purpose of the Study:

  • To develop an improved model for early Cardio Vascular Disease (CVD) prediction.
  • To enhance model performance and accuracy by focusing on feature selection and unbiased output generation.
  • To leverage the connection between Diabetic Retinopathy (DR) and CVD risk factors for more effective prediction.

Main Methods:

  • An Improvised Deep Belief Network (I-DBN) was developed for disease classification.
  • Principal Component Analysis (PCA) was employed for effective feature extraction.
  • Particle Swarm Optimization (PSO) algorithm was utilized for optimized feature selection.

Main Results:

  • The proposed I-DBN model demonstrated superior performance compared to existing state-of-the-art methods.
  • The model achieved a high prediction accuracy of 98.95% for Cardio Vascular Disease.
  • Validation confirmed the reliability of I-DBN for clinical decision support.

Conclusions:

  • The I-DBN model offers a significant advancement in the early prediction of CVD.
  • Accurate CVD risk assessment, aided by DR indicators, can be achieved through advanced machine learning techniques.
  • The developed model provides trustworthy recommendations for clinicians, improving patient treatment strategies.